Unraveling MARCH6's Role in Cancer Progression and Metabolism from Protein Homeostasis to Oncogenesis.

Malignant neoplasms are a leading cause of morbidity and mortality globally, with rising rates despite advancements in detection and treatment. This review examines the multifaceted role of MARCH6, an endoplasmic reticulum-resident E3 ubiquitin ligase, in cancer biology and disease regulation. MARCH6 exhibits a complex, context-dependent dual role: it functions as a pro-oncogenic driver in papillary thyroid carcinoma (PTC) and hepatocellular carcinoma (HCC), where it promotes cell proliferation and metastatic potential, yet simultaneously serves protective roles in non-malignant pathological conditions, including the regulation of ferroptosis, a form of iron-dependent lipid peroxidation-driven cell death, and antiviral immunity. In particular, emerging evidence suggests that MARCH6 can modulate ferroptosis through the selective degradation of key regulators such as p53 and ACSL4, thereby linking ubiquitin-mediated proteostasis to redox balance and lipid metabolism. The review synthesizes current understanding of MARCH6's structure, substrate specificity, and tissue-specific functional outcomes, emphasizing the molecular determinants of its context-dependent activity across different cellular contexts. Particular attention is given to MARCH6's regulatory impact on cholesterol and lipid metabolism, oxidative stress responses, and cell death mechanisms, with ferroptosis positioned as a central mechanistic axis through which MARCH6 may influence tumor progression and therapeutic response. Despite these mechanistic advances, critical knowledge gaps persist regarding substrate selectivity across diverse cancer types, the molecular basis of functional polarity, and therapeutic feasibility. This synthesis aims to guide future research toward harnessing MARCH6's potential as a biomarker and selective therapeutic target in cancer and stress-related diseases, particularly in the context of ferroptosis modulation, while acknowledging the inherent challenges in targeting its context-dependent functions.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-05-08
DOI
https://doi.org/10.1016/j.phrs.2026.108236
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Unraveling MARCH6's Role in Cancer Progression and Metabolism from Protein Homeostasis to Oncogenesis.

Yitao Wang, Yumiao Zhen, S Z Chen, Chung-Hang Leung et al.
PubMed
Ferroptosis and cancer prognosis
article

Unraveling MARCH6's Role in Cancer Progression and Metabolism from Protein Homeostasis to Oncogenesis.

Yitao Wang, Yumiao Zhen, S Z Chen, Chung-Hang Leung, Bo Niu, Hai-Jing Zhong
article en

Abstract

Malignant neoplasms are a leading cause of morbidity and mortality globally, with rising rates despite advancements in detection and treatment. This review examines the multifaceted role of MARCH6, an endoplasmic reticulum-resident E3 ubiquitin ligase, in cancer biology and disease regulation. MARCH6 exhibits a complex, context-dependent dual role: it functions as a pro-oncogenic driver in papillary thyroid carcinoma (PTC) and hepatocellular carcinoma (HCC), where it promotes cell proliferation and metastatic potential, yet simultaneously serves protective roles in non-malignant pathological conditions, including the regulation of ferroptosis, a form of iron-dependent lipid peroxidation-driven cell death, and antiviral immunity. In particular, emerging evidence suggests that MARCH6 can modulate ferroptosis through the selective degradation of key regulators such as p53 and ACSL4, thereby linking ubiquitin-mediated proteostasis to redox balance and lipid metabolism. The review synthesizes current understanding of MARCH6's structure, substrate specificity, and tissue-specific functional outcomes, emphasizing the molecular determinants of its context-dependent activity across different cellular contexts. Particular attention is given to MARCH6's regulatory impact on cholesterol and lipid metabolism, oxidative stress responses, and cell death mechanisms, with ferroptosis positioned as a central mechanistic axis through which MARCH6 may influence tumor progression and therapeutic response. Despite these mechanistic advances, critical knowledge gaps persist regarding substrate selectivity across diverse cancer types, the molecular basis of functional polarity, and therapeutic feasibility. This synthesis aims to guide future research toward harnessing MARCH6's potential as a biomarker and selective therapeutic target in cancer and stress-related diseases, particularly in the context of ferroptosis modulation, while acknowledging the inherent challenges in targeting its context-dependent functions.

PubMed
University of Macau (MO), Foshan Hospital of TCM (CN), Ministry of Education (TH)
Good health and well-being
Openalex Percentile: Top 6%
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.